Literature DB >> 32971520

The Gut Microbiome of Adults with Allergic Rhinitis Is Characterised by Reduced Diversity and an Altered Abundance of Key Microbial Taxa Compared to Controls.

Annabelle M Watts1, Nicholas P West1,2, Ping Zhang2, Peter K Smith3,4, Allan W Cripps5,6, Amanda J Cox1,2.   

Abstract

INTRODUCTION: Unique gut microbial colonisation patterns are associated with the onset of allergic disease in infants; however, there is insufficient evidence to determine if aberrant microbial composition patterns persist in adult allergic rhinitis (AR) sufferers.
OBJECTIVE: To compare the gut microbiome composition between adult AR sufferers and controls.
METHODS: Gut microbial composition in stool samples was compared between 57 adult AR sufferers (39.06 ± 13.29 years) and 23 controls (CG; 36.55 ± 10.51 years) via next-generation sequencing of the V3-V4 hypervariable regions of the 16S rRNA gene. Taxonomic classification and identity assignment was performed using a reference-based approach with the NCBI database of 16S rRNA gene sequences.
RESULTS: Species richness determined via the Shannon index was significantly reduced in the AR cohort compared to the CG (4.35 ± 0.59 in AR vs. 4.65 ± 0.55 in CG, p = 0.037); trends for reductions in operational taxonomic unit (OTU) counts, inverse Simpson, and CHAO1 diversity indices were also noted. Bacteroidetes (p = 0.014) was significantly more abundant in the AR group than in the CG. In contrast, the Firmicutes phylum was significantly less abundant in the AR group than in the CG (p = 0.006). An increased abundance of Parabacteroides (p = 0.008) and a reduced abundance of Oxalobacter (p = 0.001) and Clostridiales (p = 0.005) were also observed in the AR cohort compared to the CG.
CONCLUSION: Adult AR sufferers have a distinct gut microbiome profile, marked by a reduced microbial diversity and altered abundance of certain microbes compared to controls. The results of this study provide evidence that unique gut microbial patterns occur in AR sufferers in adulthood and warrant further examination in the form of mechanistic studies.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  16s rRNA gene; Allergic rhinitis; Gastrointestinal; Microbiome; Species richness

Mesh:

Substances:

Year:  2020        PMID: 32971520     DOI: 10.1159/000510536

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions.

Authors:  Zhijun Ma; Manli Qu; Xiaowu Wang
Journal:  Pol J Microbiol       Date:  2022-05-31

2.  Differential Effects of Obesity, Hyperlipidaemia, Dietary Intake and Physical Inactivity on Type I versus Type IV Allergies.

Authors:  Nathalie Rohmann; Liasita Munthe; Kristina Schlicht; Corinna Geisler; Tobias J Demetrowitsch; Corinna Bang; Julia Jensen-Kroll; Kathrin Türk; Petra Bacher; Andre Franke; Karin Schwarz; Dominik M Schulte; Matthias Laudes
Journal:  Nutrients       Date:  2022-06-05       Impact factor: 6.706

Review 3.  Influence of the Microbiome on Chronic Rhinosinusitis With and Without Polyps: An Evolving Discussion.

Authors:  Kyle S Huntley; Joshua Raber; Lauren Fine; Jonathan A Bernstein
Journal:  Front Allergy       Date:  2021-10-01

Review 4.  Effect of Probiotics on Respiratory Tract Allergic Disease and Gut Microbiota.

Authors:  Jinli Huang; Juan Zhang; Xingzhi Wang; Zenghui Jin; Panpan Zhang; Hui Su; Xin Sun
Journal:  Front Nutr       Date:  2022-02-22

Review 5.  Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers.

Authors:  Rima Hajjo; Dima A Sabbah; Abdel Qader Al Bawab
Journal:  Diagnostics (Basel)       Date:  2022-07-19

6.  Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis.

Authors:  Tsai-Yeh Chiang; Yu-Ru Yang; Ming-Ying Zhuo; Feng Yang; Ying-Fei Zhang; Chia-Hsiang Fu; Ta-Jen Lee; Wen-Hung Chung; Liang Chen; Chih-Jung Chang
Journal:  World Allergy Organ J       Date:  2022-08-06       Impact factor: 5.516

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.